EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Pharmaceutical Quality Systems in the U.S.: GMP, Quality Control and Manufacturing Compliance
Most people never think about the quality system behind their medicine They open a bottle take a tablet and trust it That trust is built on a huge amount of unglamorous work documentation testing audits and people who say stop the line when something looks off
-
Techno Trends
Glycomine’s GLM101 Receives FDA Breakthrough Therapy Designation
Glycomine has received Breakthrough Therapy designation from the US Food and Drug Administration FDA for GLM an investigational treatment for phosphomannomutase congenital disorder of glycosylation PMMCDG a rare multisystem disorder with no approved therapies
-
Projects
Hovione Opens US$100 milllion East Windsor Pharma Manufacturing Expansion
Pharmaceutical CDMO Hovione has opened a new squarefoot facility at its East Windsor campus in New Jersey completing its current US million US investment programme The expansion doubles Hoviones US spraydrying capacity and strengthens its pharmaceutical development
-
Research Insights
Salivary and serum levels of NT-proBNP, troponin, and high-sensitivity C-reactive protein in patients with heart failure
Saliva has been proposed as a noninvasive biological matrix for cardiovascular biomarker assessment However evidence regarding its agreement with bloodbased measurements in patients with heart failure remains inconsistent
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
The Chiral Blind Spot: Why AI in Drug Discovery Must Learn to See in 3D
Valliappan Kannappan
Chandramouli Ramnarayanan
AI is rapidly changing Pharma and drug discovery, yet a quiet paradox remains. A molecule’s 3D handedness shapes how it heals or harms, but many advanced models are still effectively stereo-blin...
-
2
Curcumin’s Role as an Anti-Neurofibrillary Agent Towards Alzheimer's Disease
Sabrina Ruoyao Chen Zhang
Ronny Priefer
Alzheimer’s disease is a progressive neurodegenerative disease that afflicts millions of people globally. Symptoms typically present as memory loss and cognitive decline. Existing hypthoses focu...
-
3
Analytical Testing in Pharma and Biotech: Applications, Challenges, and Future Perspectives
Venkata Reddy Pothireddy
Analytical testing ensures quality, safety, efficacy, and regulatory compliance in the pharmaceutical and biotechnology industries. It supports product development, manufacturing, stability studies, a...
-
4
Green Chemistry in Pharma: Sustainable Drug Manufacturing
Kate Williamson
Green chemistry in pharmaceutical industry is converting the customary operations to models of sails in drug manufacturing. The green pharmaceutical industry minimizes waste and carbon footprint by ta...
-
5
How to Build a Metrics-Driven Culture in Pharma Quality Management
Kavita Vengurlekar
This article explores how pharma companies can build a metrics-driven quality culture that empowers teams and strengthens regulatory trust. It highlights critical QA metrics, real-world use cases, and...
press releasesRead more...
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
ORIC Pharmaceuticals Inc Nasdaq ORIC a clinical stage oncology company focused on developing and commercializing treatments that address mechanisms of therapeutic resistance
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
Pacira BioSciences Inc NASDAQ PCRX the industry leader in its commitment to deliver innovative nonopioid pain therapies to transform the lives of patients today announced a strategic partnership with Molteni
Baker Perkins Launches ServoForm Flexi+ System to Deliver Mogul-Level Automation and Enhanced Hygiene for Confectionery and Nutraceutical Gummy Manufacturers
Baker Perkins a leading supplier of nutraceutical and food processing equipment announces the launch of the ServoForm Flexi an advanced starchfree gummy manufacturing system
FDA Grants Fast Track Designation for TRE-515 in Combination with KRAS G12C Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Trethera Corporation Trethera a clinical stage biopharmaceutical company developing firstinclass therapies for cancer and autoimmune diseases announced today that the US Food and Drug Administration
Events Read more...
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 14
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
LATEST NEWSRead more...
Psyence BioMed Partners with Benuvia to Establish U.S. Manufacturing of Pharmaceutical-Grade Ibogaine
Psyence Biomedical Ltd Nasdaq PBM through its wholly owned Texas subsidiary Texas Ibogaine Research Corporation TIRC has entered into a manufacturing services agreement with Benuvia Operations
Italfarmaco and VeriSIM Life Partner to Develop HDAC-Targeted Therapies for Neuromuscular and Rare Diseases
Italfarmaco SpA and VeriSIM Life have entered into a strategic collaboration to discover and develop novel histone deacetylase HDACtargeted therapies for neuromuscular fibrotic and rare diseases
Bayer to invest $2.2 billion in new US pharmaceutical manufacturing site
Bayer plans to invest billion in a new pharmaceutical manufacturing site in New Albany Ohio in the United States The project is part of the companys longterm growth strategy and will support its focus on innovation and patient access in the US pharmaceutical market
Italfarmaco and JCR Pharmaceuticals sign exclusive licence agreement for Hunter syndrome therapy
Italfarmaco and JCR Pharmaceuticals have entered into an exclusive licence agreement to develop and potentially commercialise JR in the United States Europe and Latin America subject to regulatory approval
AbbVie Partners with Valkai to Expand AI Use in Clinical Development
AbbVie has partnered with Valkai a life sciences artificial intelligence AI platform to expand the use of AI across selected areas of clinical development
Merck Enters into Exclusive Global License Agreement with SciBrunch Therapeutics for SPR2015, an Investigational Oral KRAS G12D (ON) Inhibitor
Lifecore Biomedical has entered into a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to million subject to the achievement of certain performance milestones
